全球隐静脉移植市场 – 行业趋势及 2029 年预测

全球隐静脉移植市场分析及规模

全球范围内，冠状动脉搭桥手术数量正在增加。事实上，每年有超过 95 万人死于心血管疾病。市场上有各种各样的医疗产品，可以帮助绕过受感染或患病的血管。根据疾病控制和预防中心 (CDC) 的数据，美国约有 850 万人患有外周动脉疾病。

• Data Bridge Market Research 分析称，预测期内隐静脉移植市场预计复合年增长率为 5.40%。这意味着市场价值（2021 年为 16.8 亿美元）到 2029 年将飙升至 25.6 亿美元。由于医院数量不断增加（尤其是在发展中经济体），“医院”在隐静脉移植市场的终端用户部分占据主导地位。Data Bridge Market Research 团队策划的市场报告包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

全球隐静脉移植市场定义

从名称本身就可以看出，隐静脉移植是指用于治疗冠状动脉搭桥术的医疗移植物。隐静脉移植的作用是通过重新连接血管，将血液从身体的一个部位引导到另一个部位。隐静脉移植用于治疗多种血管疾病。

报告范围和市场细分

Saphenous Vein Grafts Market Dynamics

Drivers

• Rising prevalence of conditions

Growing incidence rate of several cardiovascular conditions globally is one of the major factors fostering the growth of the market. Increasing incidence rate of peripheral artery disease is directly propelling the market growth rate. More than 10 million cases per year are witnessed in India and this condition may prevail for lifetime if not treated properly.    

• Research and development proficiencies

Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. Research and development proficiencies being conducted for the advancements in medical technologies and devices is also bolstering the market growth rate.

• Growing investment for healthcare facilities

Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.  

Opportunities

Furthermore, upsurge in the public-private funding for target research activities, high stress levels in young people and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2022 to 2029. Additionally, unhealthy lifestyle of individuals, rising internet penetration rate, growing rate of smoking ongoing product development and commercialization and increasing per capita expenditure on health care will further expand the market's growth rate in the future. 

Restraints/Challenges Global Saphenous Vein Grafts Market

On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities, uneven distribution of medical services, dearth of skilled medical professionals, rising geriatric population base and dearth of awareness in the backward economies are expected to obstruct market growth. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, high costs associated with the procedure, limited insurance coverage and regulatory compliance, rising number of product failure and product recalls and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2022-2029.

This saphenous vein grafts market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the saphenous vein grafts market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Saphenous Vein Grafts Market

The COVID-19 pandemic essentially affected the market. This is because of the fact that majority of the healthcare resources were directed towards meeting the demand arising out of COVID-19 patients. Postponement of non-elective surgeries and non-essential healthcare procedures has further derailed the market growth rate in this pandemic period. Further, restrictions imposed on travel owing to the lockdown regulations further challenged the market growth rate in this period. However, the post pandemic period will help to generate profits and revenues. 

Recent Development

• In February 2021, Aesculap, Inc. completed the asset acquisition of Dextera Surgical Inc. Through this acquisition, Aesculap expanded its product portfolio by adding innovative MicroCutter 5/80 staplers, PAS-Port proximal anastomosis system and innovative devices for CABG surgery to its existing medical devices which contributed in the company’s growth in the cardiothoracic surgery market which is expected to impel the global CABG market growth throughout the forecast period. 

Global Saphenous Vein Grafts Market Scope

The saphenous vein grafts market is segmented on the basis of application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Application  

• Coronary Artery Bypass Grafting (CABG)
• Arteriovenous (AV) Fistulas Access
• Vascular Reconstruction

Based on application, saphenous vein grafts market is segmented into coronary artery bypass grafting (CABG), arteriovenous (AV) fistulas access and vascular reconstruction. 

End user

• Hospitals
• Ambulatory Surgical Centers
• Others

Saphenous vein grafts market has also been segmented on the basis of end user into hospitals, ambulatory surgical centers and others.

Saphenous Vein Grafts Market Regional Analysis/Insights

The saphenous vein grafts market is analysed and market size insights and trends are provided by country, application and end user as referenced above.

The countries covered in the saphenous vein grafts market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the saphenous vein grafts market because of the strong base of healthcare facilities, widespread utilization of medications, increasing occurrence of lifestyle diseases, increasing consciousness regarding the essence of maintaining good health and rising number of research activities in this region.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, increasing occurrence of lifestyle diseases, large population pool, and the growing demand for quality healthcare in the region.

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

医疗保健基础设施增长安装基础和新技术渗透

隐静脉移植市场还为您提供了每个国家/地区资本设备医疗支出增长、隐静脉移植市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对隐静脉移植市场的影响的详细市场分析。数据涵盖 2010-2020 年的历史时期。

竞争格局和隐静脉移植市场份额分析

隐静脉移植市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对隐静脉移植市场的关注有关。

隐静脉移植市场的一些主要参与者包括：

• CryoLife, Inc.（美国）
• LifeNet Health（美国）
• LeMaitre Vascular, Inc.（美国）
• 波士顿科学公司 (美国)
• Hancock Jaffe Laboratories, Inc.（美国）
• KARL STORZ SE & Co. KG（德国）
• Getinge AB（瑞典）
• 美敦力（爱尔兰）
• Terumo Systems Corporation（日本）
• 诺华公司（瑞士）
• 辉瑞公司（美国）
• 默克公司（德国）
• 诺和诺德公司（丹麦）
• 安进公司 (美国)
• 阿斯利康（英国）
• F. Hoffmann-La Roche Ltd（瑞士）
• 赛诺菲（法国）
• 强生服务公司（美国）
• 葛兰素史克公司 (英国)
• 拜耳公司（德国）
• 百时美施贵宝公司 (美国)
• 雅培（美国）
• 博士伦公司（美国）
• BD（美国）
• AbbVie Inc.（美国）   

研究方法：全球隐静脉移植市场

数据收集和基准年分析是使用具有大样本量的数据收集模块进行的。市场数据使用市场统计和连贯模型进行分析和估计。市场份额分析和关键趋势分析也是市场报告中的主要成功因素。如需了解更多信息，请请求分析师致电或下拉询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，涉及数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请咨询我们的行业专家 https://www.databridgemarketresearch.com/zh/speak-to-analyst/?dbmr=global-saphenous-vein-grafts-market

SKU-52657